British Journal of Cancer
This journal is devoted to publishing cutting edge discovery, translational and clinical cancer research across the broad spectrum of oncology.
First phase II/III trial to verify the efficacy and safety of trifluridine/tipiracil plus bevacizumab as second-line treatment for patients with metastatic colorectal cancer
Contributors: Yasutoshi Kuboki and Takayuki Yoshino;
Department of Experimental Therapeutics and Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
A liquid biopsy signature predicts lymph node metastases in T1 esophageal squamous cell carcinoma: implications for precision treatment strategy
The treatment strategies for T1 esophageal squamous cell carcinoma (ESCC) patients with or without lymph node metastasis (LNM) are different. We demonstrated that serum miR-20b-5p could predict LNM in T1 ESCC patients.
